FDA SEC Reporting – Regulatory Reviews for SEC Forms

May 14, 2015 / Marc Sanchez /

FDA SEC Reporting

Regulatory Reviews in Form 8-K

FDA SEC Reporting 8K 10K 10Q FDA SEC Reporting does not readily come to mind when considering foods, dietary supplements, drugs, cosmetics (so call “cosmeceuticals”), or medical devices. This is because it is not often the case where FDA regulation and law overlaps or impacts the Security and Exchange Commission. One of the most common instances where the FDA and SEC overlaps is in notifications to investors under Forms 8-K, 10-K, and 10-Q. The SEC explains:

In addition to filing annual reports on Form 10-K and quarterly reports on Form 10-Q, public companies must report certain material corporate events on a more current basis. Form 8-K is the

Share this:
Posted in , , and tagged with , , , , ,
Marc Sanchez

Marc Sanchez

Marc is dedicated to helping his clients navigate the complex world of FDA and USDA legislation. He represents FDA-regulated companies in the food, dietary supplement, beverage, cosmetic, medical device, and drug industries.

Marc is the author of two textbooks and a lecturer at Northeastern University. He is a member of the Washington State Bar Association and the D.C. Bar Association.

Leave a Comment

You must be logged in to post a comment.

Categories

Are you in trouble with the FDA?

Don’t panic — you’ve got backup. Download 5 Tips to Help You Navigate FDA Enforcement and learn how to resolve the situation right now.

Expert knowledge of FDA regulations that helps you strategically grow your business

Book A Free Consultation